Conditions: Neuralgia, Postherpetic
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 280
Healthy volunteers: no

Brief summary:
This is a safety and efficacy study of AGN-214868 in patients with postherpetic neuralgia (PHN).

Detailed description:

Arms:
arm 1: AGN-214868 Dose 1 given as injections into the area of pain on Day 1. arm 2: AGN-214868 Dose 2 given as injections into the area of pain on Day 1. arm 3: AGN-214868 placebo (vehicle) given as injections into the area of pain on Day 1. arm 4: AGN-214868 Dose 3 given as injections into the area of pain on Day 1.

Interventions: intervention 1: AGN-214868 intervention 2: AGN-214868 Placebo (Vehicle)
Intervention descriptions: intervention 1: AGN-214868 given as injections into the area of pain on Day 1. intervention 2: AGN-214868 placebo (vehicle) given as injections into the area of pain on Day 1.

Protocol document: